Business Wire

XPRIZE and Musk Foundation Name 23 Winners in Five Million Dollar Carbon Removal Student Competition

10.11.2021 15:00:00 EET | Business Wire | Press release

Share

XPRIZE , the global leader in designing and implementing innovative competition models to solve the world’s grandest challenges, today announced that 23 student-led teams have won the $5M Carbon Removal Student Competition. The award program, which is part of the $100 Million XPRIZE for Carbon Removal supported by the Musk Foundation, was launched, in part, to fund early stage concepts from the next generation of carbon removal innovators and to remove barriers to entry for those interested in the main competition.

Competing student teams had the opportunity to submit their concepts for an award in one of two tracks, Carbon Dioxide Removal Demonstrations or Measurement, Reporting, and Verification Technologies . Winning student teams are able to use funds to compete in subsequent rounds of XPRIZE Carbon Removal or to develop key supporting technologies which will enable carbon dioxide removal. Points of focus for the two award tracks were as follows:

  • Carbon Dioxide Removal Demonstrations: Awards of US$250,000 to student teams intending to compete for the XPRIZE Carbon Removal Milestone and Grand Prize awards across the various carbon removal pathways: Air, Land, Rocks, Oceans. Teams needed to convince the judges that their proposed carbon removal projects would make them competitive applicants in the overall competition. This was the main focus of the Student Awards; the majority of awards are in this category.
  • Measurement, Reporting, and Verification Technologies: Awards of US$100,000 for the development of technologies that may not directly remove CO2, but will enable carbon removal. Technologies or methodologies for improving the standards of assessment, or the precision, accuracy, and time required for carbon measurements were considered.

Representing ten countries and 31 international educational institutions, the winners of the Carbon Removal Student Competition, included:

Student Carbon Removal Demonstrations:

  • Answer of Biochar (AOB) from Northeastern University, China (China)
  • E-quester from the University of Toronto (Canada)
  • BioCORE from the University of Munich (Germany)
  • Biosorra from IESE Business School and the Fuqua School of Business (Spain & United States)
  • Bison Underground affiliated with the University of Oklahoma (United States)
  • Blue Symbiosis from the University of Tasmania IMAS AMC (Australia)
  • C2 (C-Squared) from Virginia Tech and the Max Planck Institute for Biogeochemistry (Germany & United States)
  • Carbon Down Under from Southern Illinois University, Carbondale (United States)
  • CyanoCapture from the University of Oxford (United Kingdom)
  • Holocene Climate from Stanford University (United States)
  • KFC from Hohai University, Tianjin University, Shanghai Ocean University, and Chinese Academy of Fishery Sciences (China)
  • Mississippi State Energy Club - BECReative Energy from Mississippi State University (United States)
  • Monash Carbon Capture and Conversion (BioTech) from Monash University (Australia & Malaysia)
  • SASIITB from Indian Institute of Technology, Bombay (India)
  • Skyrenu Technologies from Université De Sherbrooke and Inrs-Eau Terre Environnement Research Centre (Canada)
  • Sydney Sustainable Carbon from the University of Sydney (Australia)
  • Takachar (Safi Organics) from the University of British Columbia, Northeastern University and IISC Bangalore (Canada, India, Kenya & United States)
  • UW-Madison Civil and Environmental Engineering from the University of Wisconsin, Madison (United States)

Measurement, Reporting, and Verification Technologies:

  • ACIDD Project from the University of Miami (United States)
  • BJU Global Challenges from Bob Jones University (United States)
  • Environmental Sensing from the University of Wyoming (United States)
  • PlantVillage from Pennsylvania State University (United States)
  • Working Trees from Stanford University (United States)

In order to be eligible for the Carbon Removal Student Competition, student teams needed at least 50% of their members to be currently enrolled in an educational institution with the support of an academic advisor or business leader able to act as a formal mentor. All submissions were reviewed by a panel of expert third-party judges who considered the innovation, ability to reach gigaton scale, team resources and capabilities as well as project plan feasibility in their selection process.

“We want to make a truly meaningful impact. Carbon negativity, not neutrality. The ultimate goal is scalable carbon extraction technologies that are measured based on the ‘fully considered cost per ton’ which includes the environmental impact. This is not a theoretical competition; we want teams that will build real systems that can make a measurable impact and scale to a gigaton level. Whatever it takes. Time is of the essence,” said Elon Musk, Founder and CEO of Tesla and SpaceX, in a previous statement.

Launched in April, XPRIZE Carbon Removal is a US$100M four-year global competition that invites innovators and teams from anywhere on the planet to create and demonstrate solutions that can pull carbon dioxide directly from the atmosphere or oceans. To win the grand prize, teams must demonstrate a working solution at a scale of at least 1000 tonnes removed per year; model their costs at a scale of 1 million tonnes per year; and show a pathway to achieving a scale of gigatonnes per year in future, as validated by a third party.

“Today’s college and graduate students have proclaimed that solving the climate crisis is one of the most important objectives of their generation. It’s for this reason that this student competition is so critical. Our mission is to engage, inspire and guide the next generation of climate entrepreneurs,” said Peter H. Diamandis, Founder and Executive Chairman of XPRIZE.

Any carbon negative solution is eligible: nature-based, direct air capture, oceans, mineralization, or anything else that achieves net negative emissions, sequesters CO2 durably, and shows a sustainable path to ultimately achieving gigatonne scale.

“The climate crisis is an existential threat that demands both immediate action, and a long-term commitment to bringing Earth’s carbon cycle back into balance for future generations,” said Dr. Marcius Extavour, Vice President of Climate and Environment at XPRIZE. “We’ve already begun to feel the impacts of the climate crisis in our day-to-day lives, and the data shows us that we need both immediate action on emissions reductions, and sustained innovation to develop additional tools like carbon removal. That’s why this prize is so important. It’s about mobilizing and facilitating the development of scalable solutions that can make a real difference in stabilizing the climate over the coming decades.”

For more information on XPRIZE Carbon Removal, to view the prize guidelines or to register, please visit xprize.org/carbonremoval.

About XPRIZE

XPRIZE is a global future-positive movement of over 1M people and rising, delivering truly radical breakthroughs for the benefit of humanity. XPRIZE inspires and empowers a global community of problem-solvers to positively impact our world by crowdsourcing solutions through large-scale competitions, tackling the world’s grandest challenges in exploration, environment and human equity. Active competitions include the $100 Million XPRIZE Carbon Removal with Elon Musk, $15 Million XPRIZE Feed the Next Billion, $10 Million XPRIZE Rainforest, $10 Million ANA Avatar XPRIZE, $5 Million XPRIZE Rapid Reskilling and $1 Million Digital Learning Challenge. Donate, sign up or join a team at xprize.org.

About The Musk Foundation

The Musk Foundation creates grants made in support of: renewable energy research and advocacy; human space exploration research and advocacy; pediatric research; science and engineering education; and development of safe artificial intelligence to benefit humanity.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Caden Kinard, 949-280-0182
caden.kinard@xprize.org

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 14:00:00 EEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 14:00:00 EEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 12:52:00 EEST | Press release

The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not merely a wage dispute. It stems from deep structural concerns regarding the company’s ESG management, lack of operational autonomy, and passive labor relations. Primarily, the union highlighted unresolved corporate governance issues, including allegations concerning unfair labor practices and the unauthorized use of employee personal data, which were prominently reported by South Korea's major broadcaster, MBC, in November 2025. The union believes this crisis stems from management's failure to address r

The Premier Jumping League (PJL) Launches with a Record-Breaking $300 Million Guaranteed Prize Pot, Defining a New Era for Showjumping30.3.2026 12:00:00 EEST | Press release

The Premier Jumping League (PJL) launches with a record-breaking $300 million guaranteed prize pot, defining a new era for showjumping. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330990938/en/ Photography credits: Daniel Benson for The Premier Jumping League/ Wieden+Kennedy London Backed by McCourt Global and its Executive Chairman, Frank McCourt, the PJL is a groundbreaking global competition that elevates high-performance riders and horses to their rightful place on the world stage. Built on merit, integrity, and excellence, the PJL brings together the world’s best athletes to compete for the biggest prize pot in the discipline’s history, helping to create a more resilient, long-term financial model for the sport. Represented by sixteen teams, the PJL will introduce an industry-first rider selection process from a pool of 250 of the world’s leading riders. World-class, immersive events will unfold across fourteen ic

Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy30.3.2026 12:00:00 EEST | Press release

Dompé, a leading biopharmaceutical company with operations in Italy and in the U.S., announced that the first patient has been enrolled at the Agostino Gemelli IRCCS University Hospital in Rome, Italy, in a Phase 2 investigational study of an intranasal form of Nerve Growth Factor (NGF) (Cenegermin-bkbj) for the treatment of spastic cerebral palsy (CP). On top of safety and tolerability, the study will evaluate improvements in daily functioning, quality of life, motor abilities, and neurodevelopmental measures of the Cenegermin-bkbj intranasal formulation. CP is the most common motor disability in childhood, caused by injury or changes during early brain development. The most prevalent form, spastic CP, leads to muscle stiffness and difficulty with movement.2 “Cerebral palsy is a devastating disease, and for patients and families there are still no proven treatments beyond supportive care,” said Marcello Allegretti, Chief Scientific Officer at Dompé. “With our emerging intranasal NGF p

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye